AI-Powered News Analysis•Compare coverage across the political spectrum
GoodPointsNews
Admin
Back to Dashboard
French biotech company Ipsen to buy Kartos Therapeutics for $450 million - Reuters

French biotech company Ipsen to buy Kartos Therapeutics for $450 million - Reuters

French biotech company Ipsen to buy Kartos Therapeutics for $450 million Reuters

June 29, 2026 at 01:24 PM Original source
1 agencies covered this story

Coverage by Political Leaning

See how different sides of the spectrum reported this story

Left
0 articles
No coverage
Lean Left
0 articles
No coverage
Center
1 articles
Lean Right
0 articles
No coverage
Right
0 articles
No coverage

Key People

No people linked to this story

Locations

France

Tags

acquisition biotech Ipsen Kartos Therapeutics pharmaceuticals

All Coverage

French biotech company Ipsen to buy Kartos Therapeutics for $450 million - Reuters
Reutersvia rss

<a href="https://news.google.com/rss/articles/CBMirgFBVV95cUxPZ2IxaFRzWXJfQ2hrMVVVY2puS2VZX3A4UXFJNWJmNjhTYVNKODB4RzZXNXV3RmdPRGtEbWlfcHptUk80d2kyNEJvQ1k3NkVub05fUmVZVkk5WmE4OXVUYjVSVG5RUmFyTkFPQkpILVVrTUtaX3p5aWpPRXdBNjN4bWQtUlpKMjViSm5Ld0Jwa2xlLTRQV0tXQllCN3RQYWExWW92UDZ6eklOeE9WV1E?oc=5" target="_blank">French biotech company Ipsen to buy Kartos Therapeutics for $450 million</a>&nbsp;&nbsp;<font color="#6f6f6f">Reuters</font>

100%

Similar Stories

Related coverage based on topic and tags

Nvidia-backed Iambic Therapeutics launches IPO as biotechs buck market gloom - Reuters

Nvidia-backed Iambic Therapeutics launches IPO as biotechs buck market gloom Reuters

October 8, 2026 at 06:18 PM

Viatris bets on non-opioid pain drugs with $1.65 billion Pacira deal - Reuters

Viatris bets on non-opioid pain drugs with $1.65 billion Pacira deal Reuters

October 8, 2026 at 02:39 PM

McKesson, CD&R to take infusion therapy provider Option Care private in $5.8 billion deal - Reuters

McKesson, CD&R to take infusion therapy provider Option Care private in $5.8 billion deal Reuters

October 6, 2026 at 04:30 PM

Halozyme wins court order to block Merck's injected Keytruda in select European markets - Reuters

Halozyme wins court order to block Merck's injected Keytruda in select European markets Reuters

October 7, 2026 at 05:03 PM

Argenx discontinues Vyvgart study in Sjögren's disease, shares tumble - Reuters

Argenx discontinues Vyvgart study in Sjögren's disease, shares tumble Reuters

October 8, 2026 at 08:49 PM

SpaceX seeks $40 billion to buy Nvidia chips, FT reports - Reuters

SpaceX seeks $40 billion to buy Nvidia chips, FT reports Reuters

October 6, 2026 at 10:43 PM